Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
Clinical trial NCT00112931 · COMPLETED
Trial details
- NCT number
- NCT00112931
- Sponsor
- University College, London
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2014-03-01
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.